Lucas Borrione

Lucas Borrione

Auto-generated profile, based on publicly available information

Lucas Borrione

Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Brazilian Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
LRLais Razza
Lais Razza
LSLeonardo Afonso dos Santos
Leonardo Afonso dos Santos
LBLucas Borrione
Lucas Borrione
HBHelena Bellini
Helena Bellini
LBLuis C. Branco
Luis C. Branco
ABAndre R. Brunoni
Andre R. Brunoni
Electrical and magnetic brain stimulation techniques present distinct mechanisms and efficacy in the acute treatment of depression. This was an umbrella review of meta-analyses of randomized controlled trials of brain stimulation techniques for managing acute major depressive episodes. A systematic review was performed in the PubMed/MEDLINE databases from inception until March 2020. We included the English language meta-analysis with the most randomized controlled trials on the effects of any brain stimulation technique vs. control in adults with an acute depressive episode. Continuous and dichotomous outcomes were assessed. A Measurement Tool to Assess Systematic Reviews-2 was applied and the credibility of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation framework. Seven meta-analyses were included (5,615 patients), providing evidence for different modalities of brain stimulation techniques. Three meta-analyses were evaluated as having high methodological quality, three as moderate, and one as low. The highest quality of evidence was found for high frequency-repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation, and bilateral rTMS. There is strong clinical research evidence to guide future clinical use of some techniques. Our results confirm the heterogeneity of the effects across these techniques, indicating that different mechanisms of action lead to different efficacy profiles.

1 April 2018 in Psychiatry Research
Verified
Journal Article
Open access
LBLucas Borrione
Lucas Borrione
ABAndre R. Brunoni
Andre R. Brunoni
BSBernardo Sampaio-Junior
Bernardo Sampaio-Junior
LALuana M. Aparicio
Luana M. Aparicio
AKAndrew Haddon Kemp
Andrew Haddon Kemp
RFRenerio Fraguas
Renerio Fraguas
Major depressive disorder (MDD) is associated with decreased heart rate variability (HRV), a predictor of cardiovascular morbidity by many, but not all studies. This inconsistency could be due to the association of HRV with specific depressive symptoms. Here, we investigated the association of HRV parameters with components of depressive symptoms from 120 MDD patients, at baseline of a published trial comparing the effect of sertraline to transcranial direct current stimulation. We used Principal Component Analysis to extract components of the Hamilton Rating Scale for Depression (HAM-D-17), the Montgomery Asberg Depression Rating Scale (MADRS) and the Beck Inventory for Depressive Symptomatology (BDI). We constructed one equation of multiple linear regression for each HRV parameter as the dependent variable, and the components of depressive symptoms of the three scales as the independent ones, adjusted for age and gender. A component of HAM-D-17 predicted LF/HF (low frequency/high frequency) and a component of MADRS predicted LF (low frequency). "Guilt" and "loss of interest/pleasure in activities" were present in the components of both scales, and the MADRS component also included "psychomotor retardation". These results suggest that melancholic features might be relevant for the association between MDD and HRV. Considering multiple comparisons, these results are preliminary.

1 August 2020 in Brazilian Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
LBLucas Borrione
Lucas Borrione
HBHelena Bellini
Helena Bellini
LRLais Boralli Razza
Lais Boralli Razza
AÁAna Ganho Ávila
Ana Ganho Ávila
CBChris Baeken
Chris Baeken
ABAndre R. Brunoni
Andre R. Brunoni
Current first-line treatments for major depressive disorder (MDD) include pharmacotherapy and cognitive-behavioral therapy. However, one-third of depressed patients do not achieve remission after multiple medication trials, and psychotherapy can be costly and time-consuming. Although non-implantable neuromodulation (NIN) techniques such as transcranial magnetic stimulation, transcranial direct current stimulation, electroconvulsive therapy, and magnetic seizure therapy are gaining momentum for treating MDD, the efficacy of non-convulsive techniques is still modest, whereas use of convulsive modalities is limited by their cognitive side effects. In this context, we propose that NIN techniques could benefit from a precision-oriented approach. In this review, we discuss the challenges and opportunities in implementing such a framework, focusing on enhancing NIN effects via a combination of individualized cognitive interventions, using closed-loop approaches, identifying multimodal biomarkers, using computer electric field modeling to guide targeting and quantify dosage, and using machine learning algorithms to integrate data collected at multiple biological levels and identify clinical responders. Though promising, this framework is currently limited, as previous studies have employed small samples and did not sufficiently explore pathophysiological mechanisms associated with NIN response and side effects. Moreover, cost-effectiveness analyses have not been performed. Nevertheless, further advancements in clinical trials of NIN could shift the field toward a more "precision-oriented" practice.

30 June 2021 in Neuropsychopharmacology
Verified
Journal Article
Closed access
PDF file
DTDiego Freitas Tavares
Diego Freitas Tavares
PSPaulo Suen
Paulo Suen
CSCarla Garcia Rodrigues dos Santos
Carla Garcia Rodrigues dos Santos
DMDoris Hupfeld Moreno
Doris Hupfeld Moreno
LVLeandro Da Costa Lane Valiengo
Leandro Da Costa Lane Valiengo
RMRicardo Alberto Moreno
Ricardo Alberto Moreno

21 December 2020 in Neuropsychopharmacology
Verified
Journal Article
Closed access
PDF file
SGStephan A. Goerigk
Stephan A. Goerigk
FPFrank Padberg
Frank Padberg
MBMarkus Bühner
Markus Bühner
NSNina Sarubin
Nina Sarubin
TKTyler S. Kaster
Tyler S. Kaster
ABAndre R. Brunoni
Andre R. Brunoni